These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33015197)

  • 1. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
    J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
    Saito H; Hirayama A; Umemura T; Joshita S; Mukawa K; Suga T; Tanaka E; Ota M
    PLoS One; 2018; 13(4):e0195778. PubMed ID: 29649328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.
    López-Hernández R; Campillo JA; Legaz I; Valdés M; Salama H; Boix F; Hernández-Martínez AM; Eguia J; González-Martínez G; Moya-Quiles MR; Minguela A; García-Alonso A; Carballo F; Muro M
    Microbiol Immunol; 2016 Nov; 60(11):787-792. PubMed ID: 27797112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behçet's‎ disease.
    Mohammad-Ebrahim H; Kamali-Sarvestani E; Mahmoudi M; Beigy M; Karami J; Ahmadzadeh N; Shahram F
    Scand J Rheumatol; 2018 Mar; 47(2):155-163. PubMed ID: 28862099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis.
    Fathollahi A; Aslani S; Mostafaei S; Rezaei N; Mahmoudi M
    Inflamm Res; 2018 Sep; 67(9):727-736. PubMed ID: 29869094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
    Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
    Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis.
    Wilson TJ; Jobim M; Jobim LF; Portela P; Salim PH; Rosito MA; Damin DC; Flores C; Peres A; Machado MB; Chies JA; Schwartsmann G; Roesler R
    Hum Immunol; 2010 Mar; 71(3):293-7. PubMed ID: 20036705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.
    Dastmalchi R; Farazmand A; Noshad S; Mozafari M; Mahmoudi M; Esteghamati A; Amirzargar A
    Mol Biol Rep; 2014 Aug; 41(8):5367-74. PubMed ID: 24852304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
    Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.
    Jalalvand M; Beigmohammadi F; Soltani S; Ehsan S; Rajabkhah S; Madreseh E; Akhtari M; Jamshidi A; Farhadi E; Mahmoudi M; Nafissi S
    Clin Neurol Neurosurg; 2024 Mar; 238():108171. PubMed ID: 38422742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
    Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
    Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
    Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
    Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.